being the best david brennan 1 a astrazeneca annual business review october 2003 executive vp north america aastrazeneca our commitment to btransforming ensure success bthriving in dynamic challenging environment bleveraging strengths bfocusing on growth 2 current us bslowing economy bhigh number of uninsured and underinsured bincreasing contribution from patients impact federal state issues response bpatient assistance program bcaring partners btogether rx discount card bmedicare reform bstate budget 3 challenge for industry az believe r&d is critical saves lives high demand innovative medicines declining regard favor government price controls balancing competing beliefs growing bageing population baccess quality care bamericans will pay more bprescription medication value bdifferentiated rewarded 4 market
